4-Amino-2-(pyridin-2-ylamino)pyrimidine-5-carbonitrile

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 4-Amino-2-(pyridin-2-ylamino)pyrimidine-5-carbonitrile
• 化学式: C₁₀H₈N₆
• 分子量: 212.21
• InChiKey: LTVHOCPURRSDQE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  101
• 氢给体数：
  2
• 氢受体数：
  6

文献信息

• [EN] 2-AMINOPYRIDINE SUBSTITUTED HETEROCYCLES AS INHIBITORS OF CELLULAR PROLIFERATION<br/>[FR] HETEROCYCLES 2-AMINOPYRIDINES SUBSTITUES UTILISES COMME INHIBITEURS DE LA PROLIFERATION CELLULAIRE
  申请人：WARNER LAMBERT CO

  公开号：WO2004065378A1

  公开（公告）日：2004-08-05

  The present invention provides substituted 2-aminopyridines of formula (I), wherein R1, A1, W, X, and Y are as defined in the specification, useful in treating cell proliferative disorders. The novel compounds of the present invention are potent inhibitors of cyclin-dependent kinases 4 (Cdk4).

  本发明提供了式（I）的取代2-氨基吡啶化合物，其中R1、A1、W、X和Y如规范中定义，可用于治疗细胞增殖性疾病。本发明的新化合物是cyclin-dependent kinases 4（Cdk4）的有效抑制剂。
• Combinations of signal transduction inhibitors
  申请人：Eck Louis Stephen

  公开号：US20050222163A1

  公开（公告）日：2005-10-06

  The present invention relates to methods for treating cancer comprising utilizing a combination of signal transduction inhibitors. More specifically, the present invention relates to combinations of so called cell cycle inhibitors with mitogen stimulated kinase signal transduction inhibitors, more specifically combinations of CDK inhibitors with mitogen stimulated kinase signal transduction inhibitors, more preferably MEK inhibitors. Other embodiments of the invention relate to additional combinations of the aforesaid combinations with standard anti-cancer agents such as cytotoxic agents, palliatives and antiangiogenics. Most specifically this invention relates to combinations of 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one including salt forms, which is a selective cyclin-dependent kinase 4 (CDK4) inhibitor, in combination with one or more MEK inhibitors, most preferably N-[(R)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide. The aforementioned combinations are useful for treating inflammation and cell proliferative diseases such as cancer and restenosis.

  本发明涉及治疗癌症的方法，包括利用信号转导抑制剂的组合。更具体地，本发明涉及所谓的细胞周期抑制剂与促有丝分裂原刺激激酶信号转导抑制剂的组合，更具体地说是CDK抑制剂与促有丝分裂原刺激激酶信号转导抑制剂的组合，更优选地是MEK抑制剂的组合。本发明的其他实施例涉及上述组合与标准抗癌药物（如细胞毒性药物、缓解剂和抗血管生成药物）的额外组合。最具体地，本发明涉及包括盐形式的6-乙酰基-8-环戊基-5-甲基-2-(5-哌嗪-1-基-吡啶-2-基氨基)-8H-吡啶并[2,3-d]嘧啶-7-酮，这是一种选择性细胞周期蛋白依赖性激酶4（CDK4）抑制剂，与一种或多种MEK抑制剂结合，最好是N-[(R)-2,3-二羟基-丙氧基]-3,4-二氟-2-(2-氟-4-碘苯氨基)-苯甲酰胺。前述组合对于治疗炎症和细胞增殖性疾病如癌症和再狭窄症是有用的。
• 2-Aminopyridine substituted heterocycles
  申请人：Pfizer Inc

  公开号：US20040236084A1

  公开（公告）日：2004-11-25

  The present invention provides substituted 2-aminopyridines of formula I, wherein R 1 , A 1 , W, X, and Y are as defined in the specification, useful in treating cell proliferative disorders. The novel compounds of the present invention are potent inhibitors of cyclin-dependent kinases 4 (Cdk4) 1

  本发明提供了式I的取代2-氨基吡啶，其中R1、A1、W、X和Y如规范中所定义，可用于治疗细胞增殖性疾病。本发明的新化合物是Cyclin-dependent kinases 4 (Cdk4)的有效抑制剂。
• 2-AMINOPYRIDINE SUBSTITUTED HETEROCYCLES AS INHIBITORS OF CELLULAR PROLIFERATION
  申请人：Warner-Lambert Company LLC

  公开号：EP1590341B1

  公开（公告）日：2009-06-17
• COMBINATIONS OF SIGNAL TRANSDUCTION INHIBITORS
  申请人：Pfizer Products Incorporated

  公开号：EP1740184A1

  公开（公告）日：2007-01-10